Annual reports of the ABRHP and the HMAC
Annual reports of the Advisory Board on the Registration of Homeopathic Products and the Herbal Medicines Advisory Committee.
Updates to this page
- From:
- Medicines and Healthcare products Regulatory Agency
- Published:
- 23 September 2014
- Last updated:
-
9 January 2024
Show all updates
-
Published 'ABRHP and HMAC: annual report 2021'
-
Annual Report 2020 added.
-
Added the ABRHP and HMAC: annual report 2019
-
Added 'ABRHP and HMAC: annual report 2018' as a PDF link
-
Updated ABRHP & HMAC Annual Report 2017
-
Added ABRHP and HMAC annual reports for 2015.
-
Added: ABRHP and HMAC annual report 2014
-
First published.
-
Documents
ABRHP and HMAC: annual report 2021
PDF, 619 KB, 42 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
ABRHP and HMAC: annual report 2020
PDF, 766 KB, 42 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
ABRHP and HMAC: annual report 2019
PDF, 579 KB, 35 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
ABRHP and HMAC: annual report 2018
PDF, 684 KB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
ABRHP and HMAC: annual report 2017
PDF, 947 KB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
ABRHP & HMAC Annual Report 2016
PDF, 1.19 MB, 41 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
ABRHP and HMAC: annual report 2015
PDF, 156 KB, 36 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
ABRHP and HMAC: annual report 2014
PDF, 686 KB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
ABRHP and HMAC: annual report 2013
PDF, 828 KB, 37 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
Details
Annual reports for 2 expert advisory committees of the Medicines and Healthcare products Regulatory Agency.